miRNAs in Cardiovascular Biology

MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression through inhibition of protein translation or by degradation of specific transcripts. miRNAs can regulate cardiovascular health, and be potential biomarkers or targets in cardiovascular disease. Discover the latest research on miRNAs in Cardiovascular Biology here.

May 12, 2020
Review
Open Access

Combining Nanomaterials and Developmental Pathways to Design New Treatments for Cardiac Regeneration: The Pulsing Heart of Advanced Therapies

Frontiers in Bioengineering and Biotechnology
Marco CassaniGiancarlo Forte
May 27, 2020

Circulating microRNAs overexpressed in macrosomia: an experimental and bioinformatic approach

Journal of Developmental Origins of Health and Disease
Alejandra Ortiz-DosalLuis A Salazar-Olivo
April 28, 2020
Review
Open Access

Noncoding RNAs as Biomarkers for Acute Coronary Syndrome

BioMed Research International
Lijie Wang, Yuanzhe Jin
May 23, 2020

IL-6 promotes cell adhesion in human endothelial cells via microRNA-126-3p suppression

Experimental Cell Research
Momoka OhtaMineyoshi Aoyama
May 12, 2020
Review

Long Non-Coding RNAs in Hepatocellular Carcinoma: Ordering of the Complicated lncRNA Regulatory Network and Novel Strategies for HCC Clinical Diagnosis and Treatment

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Changyao LiLei Zhang
May 16, 2020
Review

Advances and challenges in pursuing biomarkers for obstructive sleep apnea: Implications for the cardiovascular risk

Trends in Cardiovascular Medicine
Adriana LebkuchenLuciano F Drager
May 2, 2020
Open Access

Changes in Whole-Blood microRNA Profiles during the Onset and Treatment Process of Cerebral Infarction: A Human Study

International Journal of Molecular Sciences
Arata AbeTomiko Asakura
May 16, 2020

MicroRNAs as master regulators of atherosclerosis: from pathogenesis to novel therapeutic options

Antioxidants & Redox Signaling
Mohammed Rabiul HosenFelix Jansen
May 28, 2020
Review
Open Access

A Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular Disease

International Journal of Molecular Sciences
Priscilla R PrestesFadi J Charchar
May 8, 2020
Review

A Roadmap for Fixing the Heart: RNA Regulatory Networks in Cardiac Disease

Molecular Therapy. Nucleic Acids
Rong TangZhan-Peng Huang
April 29, 2020

Cardiovascular Risk and Resilience Among Black Adults: Rationale and Design of the MECA Study

Journal of the American Heart Association
Shabatun J IslamHerman Taylor
May 30, 2020
Review
Open Access

RNA-Binding Proteins in Pulmonary Hypertension

International Journal of Molecular Sciences
Hui ZhangCheng-Jun Hu
May 17, 2020

Effects of ambient ozone exposure on circulating extracellular vehicle microRNA levels in coronary artery disease patients

Journal of Toxicology and Environmental Health. Part a
Hao ChenHaiyan Tong

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

© 2020 Meta ULC. All rights reserved
/feed-previews/mirnas-in-cardiovascular-biology/93b5f618-03e6-4a05-937c-b49ef4db2578